• Moderately severe acute pain:
    • IV 30mg *1 OR 30mg QID. Max 120mg/day
    • IM 60mg *1 OR 30mg QID. Max 120 mg/day
    • PO 20mg *1 after IV/IM therapy, then 10mg every 4-6 hours. Max 40mg/day
  • Migraine-associated pain (Off-label):
    • IV 30mg *1 OR IM 60mg *1
  • Tablet:
    • 10mg
  • Injection:
    • 30mg/mL
    • 10mg/mL

IV should be injected over 15 seconds

NSAID

It reduces production of prostaglandin precursors by inhibiting COX-1 and COX-2

  • Headache
  • Nausea
  • Abdominal pain
  • Dyspepsia
  • Dizziness
  • Somnolence
  • Constipation
  • Diarrhea
  • Edema
  • Rash
  • Elevated ALT/AST
  • Fluid retention
  • Tinnitus
  • Injection site pain
  • Hypertension
  • Pruritus
  • Flatulence
  • Diaphoresis
  • Ecchymosis
  • Photosensitivity
  • Delayed ovulation
  • Hypersensitivity to class/components
  • Aspirin or NSAID-induced asthma
  • Aspirin or NSAID-induced urticaria
  • Aspirin triad
  • Epidural use
  • Intrathecal use
  • CABG surgery peri-op use
  • Major surgery pre-op use
  • Advanced renal impairment
  • Coagulation disorder
  • Active bleeding
  • GI bleeding history
  • PUD history
  • Cerebrovascular hemorrhage
  • Volume depletion
  • Pregnancy starting at 30 week gestation
  • Labor and delivery

 

WARNING

  • For short term (up to 5 days in adults) treatment of moderately severe acute pain requiring opioid-level analgesia and only as continuation of parenteral treatment
  • Total combined duration should NOT exceed 5 days
  • NOT indicated for minor or chronic pain
  • Oral treatment not indicated in children
  • Max recommended total daily dose: PO 40mg and IV/IM 120mg
  • Serious GI adverse event risk, including bleeding, ulcer and stomach or intestine perforation, which can be fatal
  • NSAIDs increase risk of serious and potentially fatal cardiovascular thrombotic events, including MI and stroke
  • Risk may occur early in treatment and may increase with duration of use
  • May adversely affect fetal circulation and inhibit uterine contractions
  • Max total daily dose 60mg IV/IM in patients >65 years if weight <50 kg, or moderately elevated Cr
  • Max single dose IM 30mg and IV 15mg in pedriatric patients
  • Aspirin
  • Celecoxib
  • Diclofenac
  • Diflunisal
  • Etodolac
  • Fenoprofen
  • Flurbiprofen
  • Ibuprofen
  • Ketoprofen
  • Ketorolac
  • Magnesium salicylate
  • Meclofenamate
  • Mefenamic acid
  • Meloxicam
  • Nabumetone
  • Naproxen
  • Oxaprozin
  • Pentoxifylline
  • Piroxicam
  • Probenecid
  • Salsalate
  • Sulindac
  • Tolmetin

                          Drug Status

Availability Prescription or OTC by Pharmacist
Pregnancy Category D
Breastfeeding Contraindicated
Schedule Not controlled
BRAND NAME STRENGTH FORMULATION PACK SIZE MANUFACTURER DISTRIBUTOR
Biorolac 30mg/mL Injection 5’s Clinica Ltd Bio-labs Ltd
Dolac 30mg/mL Injection 10’s Cadila Pharm Cadila Pharm
Dolac 10mg Tablet 10’s Cadila Pharm Cadila Pharm
Ketogress 10mg Tablet 10’s La Renon Wessex Pharma
Rolac 10mg Tablet 20’s Renata Ltd Harley’s Ltd
Rolac 30mg/mL Injection 6’s Renata Ltd Harley’s Ltd
Rolac 10mg/mL Injection 20’s Renata Ltd Harley’s Ltd